According to a filing from the Securities and Exchange Commission, a firm established by Elon Musk that will create high-tech biotechnology systems to enhance the human brain has already managed to raise more than £20m from investors.
Neuralink might need as much as $100m over the next year, although Musk, the CEO of Tesla and SpaceX, denies they are busy raising funds.
According to the filing, £20.9m has already been raised with a total offering of £77.3m. Musk was adamant, however, that his firm was not looking for outside investors, which made some suggest that the billionaire wants to fund the rest of the project himself.
Despite Musk’s denial, Bloomberg recently reported that he has embarked on a programme to raise as much as $100m to fund the company.
Although information about Neuralink and what Musk plans to achieve with it remains unclear, the firm’s main purpose is rumoured to be focussed on exploring the idea of connecting the human brain with a high-tech computer, creating the ultimate integrated network solution.
According to the firm’s website, the company is dedicated to “developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.”
The company is researching the possibility of embedding electronic devices in the human brain to improve its performance in particular areas, including memory. Neuralink is currently advertising for outstanding scientists and engineers; experience in neuroscience is not a must, but drive and talent are.
Musk himself said earlier that Neuralink’s efforts would be vital to ensure the continued existence of humanity in the light of recent developments in artificial intelligence technology.